These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33778888)

  • 1. Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015-16.
    Hopstock LA; Morseth B; Cook S; Eggen AE; Grimsgaard S; Lundblad MW; Løchen ML; Mathiesen E; Nilsen A; Njølstad I
    Eur J Prev Cardiol; 2022 Mar; 29(2):362-370. PubMed ID: 33778888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis.
    Bohn B; Schöfl C; Zimmer V; Hummel M; Heise N; Siegel E; Karges W; Riedl M; Holl RW;
    Cardiovasc Diabetol; 2016 May; 15():72. PubMed ID: 27141979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study.
    Leosdottir M; Hagstrom E; Hadziosmanovic N; Norhammar A; Lindahl B; Hambraeus K; Jernberg T; Bäck M
    BMJ Open; 2023 May; 13(5):e069770. PubMed ID: 37173109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in adiposity, physical activity, cardiometabolic risk factors, diet, physical capacity and well-being in inactive women and men aged 57-74 years with obesity and cardiovascular risk - A 6-month complex lifestyle intervention with 6-month follow-up.
    Hopstock LA; Deraas TS; Henriksen A; Martiny-Huenger T; Grimsgaard S
    PLoS One; 2021; 16(8):e0256631. PubMed ID: 34432850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.
    Gynnild MN; Aakerøy R; Spigset O; Askim T; Beyer MK; Ihle-Hansen H; Munthe-Kaas R; Knapskog AB; Lydersen S; Naess H; Røsstad TG; Seljeseth YM; Thingstad P; Saltvedt I; Ellekjaer H
    J Intern Med; 2021 Mar; 289(3):355-368. PubMed ID: 32743852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention care and effect: Total and low-density lipoprotein cholesterol levels and lipid-lowering drug use in women and men after incident myocardial infarction - The Tromsø Study 1994-2016.
    Hopstock LA; Eggen AE; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T
    Eur J Cardiovasc Nurs; 2018 Aug; 17(6):563-570. PubMed ID: 29488799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index, waist circumference and cardiovascular diseases in transitional ages (40 and 66 years).
    Yoo JE; Han K; Jung JH; Hur YI; Kim YH; Kim ES; Son JW; Rhee EJ; Lee WY; Nam GE
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):369-381. PubMed ID: 36522803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromsø study.
    Hagen AN; Ariansen I; Hanssen TA; Lappegård KT; Eggen AE; Løchen ML; Njølstad I; Wilsgaard T; Hopstock LA
    Eur Heart J Open; 2022 Sep; 2(5):oeac061. PubMed ID: 36284643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW;
    Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between lifestyle habits and cardiovascular risk factors in familial hypercholesterolemia.
    Dessureault L; Roy G; Couture P; Gangloff A; Guasch-Ferré M; Pérusse L; Tremblay A; Drouin-Chartier JP
    Nutr Metab Cardiovasc Dis; 2023 Oct; 33(10):2044-2052. PubMed ID: 37543519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to lifestyle recommendations among Norwegian cancer survivors and the impact of traditional and complementary medicine use: the Tromsø Study 2015-2016.
    Nakandi K; Benebo FO; Hopstock LA; Stub T; Kristoffersen AE
    BMC Complement Med Ther; 2023 Aug; 23(1):292. PubMed ID: 37598174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations.
    Sakalaki M; Barywani S; Rosengren A; Björck L; Fu M
    BMC Cardiovasc Disord; 2019 Nov; 19(1):243. PubMed ID: 31694556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
    Khan NA; Hemmelgarn B; Herman RJ; Bell CM; Mahon JL; Leiter LA; Rabkin SW; Hill MD; Padwal R; Touyz RM; Larochelle P; Feldman RD; Schiffrin EL; Campbell NR; Moe G; Prasad R; Arnold MO; Campbell TS; Milot A; Stone JA; Jones C; Ogilvie RI; Hamet P; Fodor G; Carruthers G; Burns KD; Ruzicka M; DeChamplain J; Pylypchuk G; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Vallée M; Howlett J; Bacon SL; Lindsay P; Gilbert RE; Lewanczuk RZ; Tobe S;
    Can J Cardiol; 2009 May; 25(5):287-98. PubMed ID: 19417859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study.
    Akesson A; Larsson SC; Discacciati A; Wolk A
    J Am Coll Cardiol; 2014 Sep; 64(13):1299-306. PubMed ID: 25257629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonfatal acute myocardial infarction in Costa Rica: modifiable risk factors, population-attributable risks, and adherence to dietary guidelines.
    Kabagambe EK; Baylin A; Campos H
    Circulation; 2007 Mar; 115(9):1075-81. PubMed ID: 17339565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
    Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
    Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study-the Tromsø Study.
    Wilsgaard T; Vangen-Lønne AM; Mathiesen E; Løchen ML; Njølstad I; Heiss G; Danaei G
    BMJ Open; 2020 May; 10(5):e035584. PubMed ID: 32448794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study.
    Hagström E; Sorio Vilela F; Svensson MK; Hallberg S; Söreskog E; Villa G
    Adv Ther; 2021 Sep; 38(9):4695-4708. PubMed ID: 34312813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.